Development of combination adjuvant for efficient T cell and antibody response induction against protein antigen

Most current clinical vaccines work primarily by inducing the production of neutralizing antibodies against pathogens. Vaccine adjuvants that efficiently induce T cell responses to protein antigens need to be developed. In this study, we developed a new combination adjuvant consisting of 1,2-dioleoy...

Descripción completa

Detalles Bibliográficos
Autores principales: Haseda, Yasunari, Munakata, Lisa, Kimura, Chiyo, Kinugasa-Katayama, Yumi, Mori, Yasuko, Suzuki, Ryo, Aoshi, Taiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328330/
https://www.ncbi.nlm.nih.gov/pubmed/34339430
http://dx.doi.org/10.1371/journal.pone.0254628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328330/
https://www.ncbi.nlm.nih.gov/pubmed/34339430
http://dx.doi.org/10.1371/journal.pone.0254628

Ejemplares similares